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I am from the North Carolina Research Campus, which is devoted to nutrition, agriculture, 
biotechnology and functional food. Scientists from seven universities on this campus are 
focused on specialty crops that provide bioactive compounds, which, when you ingest 
them or put them on your skin topically, they interface with human therapeutic targets to 
counteract chronic disease or bolster metabolism to increase endurance. These are the crops 
that your grandmother said you should eat, and maybe you didn’t because you didn’t like 
vegetables. We are going beyond what grandma said, going beyond anecdotal evidence to 
try to elucidate biomarkers: what are the mechanisms of action of compounds in specialty 
crops that help them to interact with human therapeutic targets and counteract disease? 
What are these bioactive phytochemicals or “phytoactives” (Figure )?
Not all phytochemicals are important for human health, but phytoactives are those 
that bolster human health in some way, and many are present in specialty crops.
It’s important to note that phytoactives are not necessarily plant nutrients. Of course, 
specialty crops contain nutrients as well: minerals, vitamins, etc., that build strong bones 
and teeth. The phytoactives tend to be secondary compounds, not necessary for the plant to 
grow but which help human metabolism. They include pigments, anthocyanins, betalains, 
chlorophylls and carotenoids, which provides a convenient message for consumers: “Put 
some color on your plate. Don’t just eat foods that are brown and white.” When you do 
put color on your plate, you tend to be consuming phytoactive compounds, which are 
associated with pigments in many specialty crops. Concentrations and profiles of phytoac-
tives vary with species and variety. Some sources are richer than others and some are more 
efficacious against certain disease conditions than others, but they are all there.
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Figure . Bioactive phytochemicals—“phytoactives”—are natural compounds in fruits, 
vegetables, nuts and grains that positively affect human health.
At the Plants for Human Health Institute on the North Carolina Research Campus, 
we are investigating the gamut, from whole foods to functional foods to phytopharma-
ceuticals, i.e. removing and purifying an active compound from a plant and putting it 
into a pill, like a pharmaceutical. However, our major focus is on whole foods derived 
from specialty crops. For this presentation, I will address four questions:
• Why the Current Attention?
• How do Phytoactives Modulate Human Health?
• Can Genomics, Metabolomics, etc., Pinpoint How Phytoactives Work?
• What’s the Reaction in the Marketplace?
Why the Current Attention?
You can hardly open a general-interest magazine or the popular section of a newspaper 
without finding something on functional foods. After Oprah Winfrey said that she “pops” 
blueberries like M&Ms during the day, sales of blueberries went through the roof. I talk 
about berries a lot because that’s my area of research, and, inevitably, the talk-show host 
will say, “This is wonderful, but why are we learning about it only now?” In fact, we are 
not just learning about it today. This is ancient stuff. Traditional ecological knowledge 
includes a lot on specialty crops—not named as such, of course—and their impacts on 
health: fruits, vegetables, spices, herbs, etc. The science hasn’t been behind them until now, 
and with the tools we have today, we are able to characterize the compounds involved. 
With animal models and clinical trials, we can determine how phytoactives interact in 
the human body, clearance times and locations of accumulation. We finally have the tools 
to investigate how these things are working.
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To make the jump from traditional ecological knowledge to science now, it’s important 
to realize why plants synthesize these compounds. Usually they are produced in response 
to environmental stress. We like to say “stressed for success” because plants, being sessile, 
need a cornucopia of chemical defenses against disease, insect infestation, nematode at-
tacks, UV light, and so on. They need those defenses to survive, and they are the same 
compounds that, when we ingest them, counteract chronic disease.
How do Phytoactives Modulate Human Health?
How do phytoactives modulate human health, whether it be from a pharmaceutical, 
cosmeceutical or functional food standpoint? It would be advantageous if functional 
foods or wild plants that have phytoactive compounds acted like pharmaceuticals, with 
a nice bridge between using a plant to protect your health and using a pill to protect your 
health. But, plants don’t work like that. They contain complex, interacting mixtures of 
compounds each of which may potentiate effects in the human body. It’s hard to sort out 
the multiplicity of bioactivities. The compounds can do a number of different things. 
They might have activities against cancer and the same little group of compounds may be 
active also against cardiovascular disease. It’s tough for doctors and scientists to understand, 
tending to mitigate against using specialty crops in medical treatments.
Can ’Omics Pinpoint How Phytoactives Work?
With a pharmaceutical, you have a single active compound in a pill, facilitating dose-
response and human efficacy tests. But when it’s a plant extract and you tease out the 
components and pick out an active fraction via some activity in a bioassay, a lot of times 
when you purify the compound, you lose the activity. What’s going on? A lot of times 
with plants, a synergistic effect of a potentiating compound on an active compound results 
in the “big bang” for human health. So there may be a multiplicity of bioactivities; blue-
berry is a good example. Positive effects on urinary tract infections have been attributed 
to blueberries—much like to cranberries—as well as beneficial effects on cardiovascular, 
optic, cancer and brain-function problems.
On the other hand,  skepticism exists on the part of doctors, because they need to 
understand the biomarkers and see the proof. So, “omics” is one way to provide proof. We 
are starting to use genomics, transcriptomics, proteomics and, especially, metabolomics. 
If you have those tools in your hand, you can do a lot to decipher how active compounds 
are working, to pinpoint biomarkers. 
We have a blueberry-genome sequencing effort that will be completed by the end of 
summer 03. It’s a complicated genome that no one else wanted to tackle. The database 
will be open to people looking at cranberry and other plants in the genus Vaccinium. 
Knowing the genomics leads to understanding activities within the human body.
The launch of the Plant Pathways Elucidation Project (“P-Squared EP”) is planned for 
June 03. North Carolina State and the University of North Carolina-Charlotte will be 
academic partners. At NC State we will handle the biology whereas Charlotte will handle 
bioinformatics; the biological data that we generate will go into a knowledge-based cloud 
over the whole project to feed information into what a plant makes, how it makes it, 
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what’s the pathway it takes to get there, and, finally  what good the product is for hu-
man health. In building this knowledge base, Dole and General Mills will be industry 
partners and Castle & Cooke will be a sponsor. Developed technologies will help us to 
understand how specialty crops contribute to human health; can we quantify it so that 
it’s validated in every way?
General Mills and Dole have opened their files on pathways they have elucidated for 
oat, pineapple, and berries, and they are looking to the university researchers to pull 
together teams for complex pathway analyses. We will initiate the effort in two weeks, 
focusing on four crops with input from our industry partners: oat (Avena sativa), broccoli 
(Brassica oleracea), strawberry (Fragaria x ananassa) and blueberry (Vaccinium spp.). Five 
newly recruited PhD students will start on June 0, 03, each of whom will supervise 
six undergraduate summer interns to put together pathways. Almost $ million have been 
provided by the UNC general administration to jumpstart the effort and to ensure that 
the PhD students will have funding for four years. It’s exciting to get this going because 
it involves tools that we already had but we needed manpower to put them to work to 
generate useful data. Several local junior colleges and schools in the UNC system are 
donating interns. We will not donate any, but we will pay the interns to work intensively 
with the PhD students as teams. 
Clinical Trials
Another example of how we get to the bottom of how specialty crops work is with clinical 
trials. These have always been horribly expensive, which is why they have not been used to 
investigate specialty crops or functional foods. We are fortunate to be partnering with the 
Appalachian State University and members of their human performance laboratory where 
they do clinicals, many with athletes—runners, cyclists, NASCAR pit crews, etc.—looking 
at the effects of functional-food components on exercise performance. For example we have 
done some work with runners, supplementing their diets with blueberries and green tea 
to see the effects of polyphenolics on classic markers of inflammation and oxidative stress 
using metabolomics. Classically you don’t see oxidative stress or inflammation changes in 
highly trained athletes, but a nice thing about athletes is that they will cooperate if they 
think that the process will improve their performance and make them stronger. You don’t 
have to pay them as much as for a normal clinical trial and they permit biopsies.
After consuming a supplement of blueberry green tea for 4 days, athletes were ex-
posed to periods of intensive exercise, sufficient to induce oxidative stress (Figure ). 
Only insignificant differences between the placebo and treatment groups were seen in 
the gross markers of oxidative stress like C-reactive protein. But we did see differences in 
bioavailability. The athletes who were supplemented had excellent profiles of gut bacteria 
metabolism of phenolic phytochemicals. We saw, for the first time, that compounds from 
blueberry and green tea were actually getting into the blood of the athletes, intensified 
by kind of a gut leakiness with intensive exercise which persisted during the recovery 
period, so that bioavailability was intensified as revealed by the polyphenolic signature. 
Gut microbial metabolism of the plant polyphenols was clear in the treatment group 
versus the placebo group. Furthermore, runners who were supplemented with blueberry 
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green tea protein continued to utilize fatty acids—they had higher ketogenesis—during 
the recovery period. Athletes show a burst in oxidative stress and fat burning while they 
are exercising, but, whereas the placebo group went down to normal levels during the 
4-hour recovery period, fat burning continued in the treatment group, which was 
quantifiable using metabolomics.
Reaction in the Marketplace 
Wild blueberries have been harvested commercially for many years in Maine and the 
maritime provinces of Canada; it’s backbreaking work (Figure 3). Although it was the 
second largest industry in Maine, it was not highly lucrative for farmers until, in 998, 
the “antioxidant” message emerged (Figure 4).
This wild blueberry antioxidant message was confirmed by researchers in Canada and 
the United States, and later in Europe. A lot of work has been done on wild blueberries 
and diabetes and obesity. Data from clinical trials at the Pennington Biomedical Research 
Center are conclusive for efficacy of blueberries for increasing satiety in their patients and 
cutting triglyceride levels. For hyperglycemia—the hallmark of diabetes—wild blueber-
ries did better than metformin, the drug of choice for diabetes; blood-glucose levels were 
reduced in six hours. These and similar data attracted much media attention.
In 999, colleagues at Tufts University, Barbara Shukett-Hale and James Joseph, showed 
that inclusion of blueberries at  percent of the diet alleviated or prevented the symptoms 
of dementia in artificially aged rats. Furthermore, losses in cognitive and motor function 
were partially replenished by introduction of the blueberry diet. This and similar research, 
reported in the mass media, have taken the humble blueberry from an addition to muf-
Figure . What are the effects of phytoactives on athletic performance?
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Figure 3. Labor-intensive harvesting of wild blueberries in Maine.
Figure 4. Nature’s # antioxidant fruit.
43
Figure 5. Blueberry production trend (×06 pounds/year).
fins to a health icon. These days, it’s hard to pick up a health-related magazine without 
finding something about blueberries in particular. Other functional foods from specialty 
crops have benefitted in the same way, because people are turned on to what they can do 
proactively for their health.
Figure 5 shows increased production of cultivated and wild blueberries since 998 
when news of positive health effects first made the headlines.
We know what we’re supposed to eat and we know how much we’re supposed to eat. 
However, it’s estimated that approximately  percent of the American public—including 
educated people—actually eats the amount of fruits and vegetables they’re supposed to 
eat. There are many reasons why people don’t do what they’re supposed to do. How do 
we take bioactives from fruits and vegetables, from specialty crops, and get them in a 
shelf-stable, convenient form to more people?
We are working with the US Army to develop ways of getting fruits and vegetables to 
soldiers in the field. Figure 6 shows shelf-stable, low-sugar protein-rich flours containing 
extract from muscadine grapes. The same can be done with kale extract. The preparations 
are stable for over three years in some cases. Soldiers in the field will eat it because it tastes 
good, it’s nutty, and they don’t care if it’s GMO or not. 
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Figure 6. One-step sorption of the medium polarity polyphenolics in muscadine juice, 
free of unwanted/non-nutritional material.
plinary discovery and outreach, the team at the PHHI is pioneering a dramatic 
shift in the way the American public views and uses food crops, not merely as a 
source of nutrients and flavorful calories, but as sources of powerful components 
that protect and enhance human health. Her research team focuses on wild and 
 domesticated berries and their wide-ranging health benefits, including alleviation 
of the symptoms of diabetes and metabolic syndrome. Current efforts include 
a Bill & Melinda Gates Foundation Grand Exploration Challenges project in 
Zambia and projects in Egypt, Central Asia, Oceania, Mexico, Ecuador, Chile, 
subSaharan Africa and New Zealand.
 Formerly (2006–2008), she was director of ACES Global Connect (the interna-
tional arm of the College of Agriculture, Consumer and Environmental Sciences 
at the University of Illinois) and associate director of the Functional Foods for 
Health Program (997–000) at the University of Illinois. She is vice president of 
the Global Institute for BioExploration, an R&D network that promotes ethical, 
natural product-based pharmacological bioexploration to benefit human health 
and the environment in developing countries.
